Drug intelligence / Profile preview

Vitanex

Development stage: Unknown
Lead developer: Emblazon Life Sciences
Modality: Small Molecules
Administration: Oral

Overview

Vitanex is a marketed nutraceutical product developed by Emblazon Life Sciences. It is a combination formulation typically consisting of lycopene, essential vitamins (such as A, C, and E), and minerals (including zinc and selenium). The product is designed to provide antioxidant support and supplement daily nutritional intake to prevent or treat micronutrient deficiencies. It is part of the company's Aura brand division and is available as an oral formulation. Vitanex is intended to support overall metabolic health, boost immunity, and reduce oxidative stress in the body.

Brand names: Vitanex

Beyond the preview

Go deeper on Vitanex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitanex.

Explore the full profile